Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Am J Transplant. 2012 Jul 3;12(11):2958–2965. doi: 10.1111/j.1600-6143.2012.04177.x

Table 3.

Multivariable Cox Regression Analysis of End-Stage Renal Disease after Liver-alone Transplant, Censored for Death*

Characteristic Hazard Ratio Confidence Interval P
eGFR category
 Group 1: eGFR always ≥30 ml/min/m2 Reference Reference Reference
 Group 2: eGFR fluctuated above and below 30 ml/min/m2 1.66 (1.19, 2.32) 0.003
 Group 3: eGFR always <30 ml/min/m2 7.23 (4.08, 12.8) <0.001
 Group 4: Any Dialysis 2.69 (1.55, 4.68) <0.001
Pre-transplant diabetes 2.65 (1.97, 3.59) <0.001
Black race versus other 1.83 (1.09, 3.06) 0.021
Male 1.51 (1.11, 2.06) 0.009
Total bilirubin lowest tertile (<2.2 mg/dL) Reference Reference Reference
Total bilirubin middle tertile (2.2–4.4 mg/dL) 0.73 (0.52, 1.02) 0.066
Total bilirubin highest tertile (>4.4 mg/dL) 0.40 (0.25, 0.63) <0.001
Serum albumin lowest tertile (<2.7 g/dL) Reference Reference Reference
Serum albumin middle tertile (2.7–3.1 g/dL) 0.72 (0.51, 1.02) 0.066
Serum albumin highest tertile (>3.1 g/dL) 0.61 (0.43, 0.88) 0.007
Serum sodium lowest tertile (<134 mEq/L) Reference Reference Reference
Serum sodium middle tertile (134–138 mEq/L) 1.39 (0.96, 2.01) 0.085
Serum sodium highest tertile (>138 mEq/L ) 2.40 (1.64, 3.52) <0.001
*

Model also adjusted for age-strata, pre-transplant hypertension, cause of liver disease, and international normalized ratio of prothrombin time at transplant. None of these variables were significantly associated with the outcome.